Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System

RxCUI: 310176
RxNorm name: Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System
Display name: Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System
Full name: Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vivelle-Dot	ESTRADIOL	Sandoz Inc	5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	2023-11-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 310176

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00208 MG/HR Transdermal System [Vivelle] [SBD] · 84 HR Vivelle 0.00208 MG/HR Transdermal System [SY] · Vivelle Dot 0.05 MG/24HR Twice Weekly Transdermal Patch [SY] · Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System [SY]	5	17	These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 1996	20231117
03ab0226-b494-4607-8e8b-7381082fa780	Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00208 MG/HR Transdermal System [Vivelle] [SBD] · 84 HR Vivelle 0.00208 MG/HR Transdermal System [SY] · Vivelle Dot 0.05 MG/24HR Twice Weekly Transdermal Patch [SY] · Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System [SY]	5	1	Vivelle-Dot	20120217